Related Experiment Video
Updated: Jul 18, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
Noninvasive Modulation of the Subcallosal Cingulate and Depression With Focused Ultrasonic Waves
Thomas S Riis1, Daniel A Feldman2, Sarah S Kwon3
1Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah.
Noninvasive ultrasonic stimulation of the subcallosal cingulate cortex (SCC) shows promise for treating depression. This new approach successfully modulated SCC activity and improved mood in patients with treatment-resistant depression.
Area of Science:
- Neuroscience
- Neuromodulation
- Psychiatry
Background:
- Excessive subcallosal cingulate cortex (SCC) activity is linked to severe depression.
- Surgical SCC stimulation alleviates depression, but noninvasive methods lack deep-target precision.
- A novel noninvasive approach using low-intensity focused ultrasound to modulate the SCC was developed.
Purpose of the Study:
- To assess the efficacy of noninvasive ultrasonic stimulation of the SCC in patients with treatment-resistant depression.
- To evaluate the ability of focused ultrasound to selectively target and modulate deep brain structures like the SCC.
- To investigate the impact of SCC neuromodulation on mood and depression severity.
Main Methods:
- A randomized, double-blind, sham-controlled study involving 22 individuals with treatment-resistant depression.
- Concurrent functional magnetic resonance imaging (fMRI) was used to quantify target engagement during ultrasonic stimulation of the bilateral SCC.
- Mood state and depression severity were assessed using the Sadness subscale of the Positive and Negative Affect Schedule and the 6-item Hamilton Depression Rating Scale.
Main Results:
- fMRI confirmed a target-specific decrease in SCC activity during real stimulation (p = .028).
- Neuromodulation at the individual participant level was detectable in 7 of 16 participants with a single 10-minute scan (p < .05).
- Real SCC stimulation led to greater improvements in mood and depression scores compared to sham stimulation (p < .05).
Conclusions:
- Ultrasonic stimulation effectively modulates SCC activity and rapidly reduces depressive symptoms in a pilot study.
- Noninvasive, selective targeting of deep brain areas opens new avenues for circuit-directed therapeutics.
- This technology offers potential for analyzing deep-brain circuit function in humans noninvasively.
More Related Videos
05:19Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
08:38Author Spotlight: Integration of Fiber Photometry and Focused Ultrasound Neuromodulation for Investigating Neural Modulation in Freely Moving Mice
Published on: September 6, 2024